John T Chang Selected Research

John T Chang Research Topics

Disease

10	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 04/2006
7	Ulcerative Colitis 01/2022 - 09/2014
6	Crohn Disease (Crohn's Disease) 01/2021 - 09/2014
4	Infections 10/2020 - 03/2015
3	Colitis 01/2022 - 01/2017
3	Inflammation (Inflammations) 01/2022 - 03/2015
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2015
1	Reinfection 10/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Hemorrhage 10/2018
1	Genetic Risk Score 01/2018
1	Dysbiosis 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Shock 01/2018
1	Carcinoma (Carcinomatosis) 04/2016
1	Neoplasms (Cancer) 04/2016
1	Intestinal Polyposis (Polyposis, Intestinal) 01/2016
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015
1	Botulism 01/2015
1	Rheumatoid Arthritis 09/2014
1	Toxic Megacolon 12/2012
1	Autoimmune Diseases (Autoimmune Disease) 07/2011
1	Thyroid Neoplasms (Thyroid Cancer) 11/2010
1	Osteoarthritis 04/2006
1	Barrett Esophagus (Barrett's Esophagus) 07/2004
1	Adenocarcinoma 07/2004
1	Asthma (Bronchial Asthma) 05/2004
1	Heart Failure 05/2004
1	Pain (Aches) 05/2004
1	Stroke (Strokes) 11/2003

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
4	vedolizumabIBA 12/2020 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2017
2	AntigensIBA 10/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 02/2015
2	CytokinesIBA 03/2015 - 02/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	VaccinesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 11/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2021
1	Dextrans (Dextran)FDA Link 11/2021
1	Small Cytoplasmic RNAIBA 01/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 10/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	NucleotidesIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018
1	ChromatinIBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	Proteasome InhibitorsIBA 04/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2016
1	Infliximab (Remicade)FDA Link 01/2016
1	Tamoxifen FDA LinkGeneric 10/2015
1	Immunoglobulin G (IgG)IBA 03/2015
1	InterleukinsIBA 03/2015
1	Messenger RNA (mRNA)IBA 02/2015
1	AntitoxinsIBA 01/2015
1	Janus KinasesIBA 09/2014
1	tofacitinibIBA 09/2014
1	Janus Kinase InhibitorsIBA 09/2014
1	IntegrinsIBA 07/2011
1	IodineIBA 11/2010
1	Pharmaceutical PreparationsIBA 04/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2006
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2004
1	ElementsIBA 05/2004

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2004
3	Colectomy 01/2021 - 12/2012
2	Hyperbaric Oxygenation 01/2022 - 10/2018
1	Biological Therapy 10/2018
1	Aftercare (After-Treatment) 02/2015
1	Terminal Care (Care, Terminal) 11/2003